The stock dropped 5.17% after-hours following a reverse stock split announcement to regain Nasdaq compliance. The company has declined 77.99% over 12 months, indicating severe underperformance and financial distress. Reverse splits are typically viewed negatively by markets as they signal struggling companies attempting to meet listing requirements.
Sunshine Biopharma news
$0.7874−3.73%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Sunshine Biopharma
BenzingaMay 29, 2:16 AM ET▼ Negative
Also mentions SBFM
Articles that tag SBFM but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology